The Human Research Ethics Committee (HREC) in Australia has granted clearance for Cullinan Therapeutics to commence an ...
Sohan Roy, well-known Indian businessman settled in UAE, created a remarkable moment when he became the pioneering Indian to ...
Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for ...
Nicholas Cullinan, the new director of the British Museum, has announced a groundbreaking $1.3 billion transformation plan, ...
BTIG analyst Julian Harrison maintained a Buy rating on Cullinan Management (CGEM – Research Report) yesterday and set a price target of ...
Wedbush analyst Robert Driscoll initiated coverage with a Buy rating on Cullinan Management (CGEM – Research Report) today and set a ...
The exhibit is open to the public on Fridays to Sundays, from September 13 to October 6. Entrance is free, but donations are ...
Journal Star on MSN2d
City of Peoria looks to purchase major downtown buildings for $1.75 million. Here's whyOn Tuesday, the Peoria City Council is scheduled to review a proposal from city staff to purchase the 11-story PNC Building, ...
Irish Examiner on MSN3h
Aidan McCarthy return helps Inagh-Kilnamona past Éire Óg into Clare semiInagh-Kilnamona 2-16 Éire Óg 0-20 The perceived advantage of being a group winner was emphatically debunked as ...
When you put Toyota and luxury together, you generally get a Lexus but the Japanese company has developed several luxury ...
From a $240,000 Mercedes to an ultra-exclusive $500,000 Maybach. Here's a look at Odell Beckham Jr.'s car collection and the ...
Stifel has recently initiated Cullinan Therapeutics Inc (CGEM) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on April 15, 2024, William Blair had initiated the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback